Desensitization strategies enabling successful renal transplantation in highly sensitized patients.

Item

http://www.wikidata.org/entity/Q36652013

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Desensitization strategies ena ...... in highly sensitized patients.

@ast

Desensitization strategies ena ...... in highly sensitized patients.

@en

type

Item

label

Desensitization strategies ena ...... in highly sensitized patients.

@ast

Desensitization strategies ena ...... in highly sensitized patients.

@en

prefLabel

Desensitization strategies ena ...... in highly sensitized patients.

@ast

Desensitization strategies ena ...... in highly sensitized patients.

@en

P1476

Desensitization strategies ena ...... in highly sensitized patients.

@en

P2093

Beimler JH

http://www.w3.org/2001/XMLSchema#string

Susal C

http://www.w3.org/2001/XMLSchema#string

Zeier M

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics.

Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols.

Toward performing transplantation in highly sensitized patients.

Mycophenolate mofetil decreases antibody production after cardiac transplantation.

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.

Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients.

Predicting kidney graft failure by HLA antibodies: a prospective trial.

A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

P304

7-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-0012.2006.00594.X

http://www.w3.org/2001/XMLSchema#string

P478

20 Suppl 17

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17100695

http://www.w3.org/2001/XMLSchema#string